Itron (ITRI) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Werte in diesem Artikel
For the quarter ended June 2025, Itron (ITRI) reported revenue of $606.76 million, down 0.4% over the same period last year. EPS came in at $1.62, compared to $1.21 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $609.26 million, representing a surprise of -0.41%. The company delivered an EPS surprise of +21.8%, with the consensus EPS estimate being $1.33.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Itron performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Device Solutions: $112.76 million compared to the $113.1 million average estimate based on four analysts. The reported number represents a change of -4.9% year over year.Revenue- Outcomes: $85.07 million versus the four-analyst average estimate of $85.73 million. The reported number represents a year-over-year change of +9.3%.Revenue- Networked Solutions: $408.93 million versus the four-analyst average estimate of $411.45 million. The reported number represents a year-over-year change of -0.9%.Service Revenue- Networked Solutions: $29.45 million versus the three-analyst average estimate of $24.94 million. The reported number represents a year-over-year change of +16.2%.Product Revenue- Device Solutions: $111.94 million compared to the $111.07 million average estimate based on three analysts. The reported number represents a change of -5.1% year over year.Product Revenue- Networked Solutions: $379.48 million versus the three-analyst average estimate of $386.09 million. The reported number represents a year-over-year change of -2%.Revenue- Total Service Revenue: $89.58 million versus the three-analyst average estimate of $77.61 million. The reported number represents a year-over-year change of +17.6%.Revenue- Total Product Revenue: $517.18 million compared to the $531.86 million average estimate based on three analysts. The reported number represents a change of -3% year over year.Service Revenue- Outcomes: $59.3 million versus the two-analyst average estimate of $53.57 million. The reported number represents a year-over-year change of +18.2%.Service Revenue- Device Solutions: $0.82 million versus the two-analyst average estimate of $0.57 million. The reported number represents a year-over-year change of +32.2%.Product Revenue- Outcomes: $25.76 million versus the two-analyst average estimate of $31.33 million. The reported number represents a year-over-year change of -6.7%.Gross Profit- Device Solutions: $33.59 million versus the two-analyst average estimate of $30.33 million.View all Key Company Metrics for Itron here>>>Shares of Itron have returned +3.2% over the past month versus the Zacks S&P 500 composite's +2.7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.One Big Gain, Every Trading DayTo help you take full advantage of this market, you’re invited to access every stock recommendation in all our private portfolios - for just $1.Zacks private portfolio services that closed 256 double and triple-digit winners in 2024 alone. That’s about one big gain every day the market was open. Of course, not all our picks are winners, but members have seen recent gains as high as +627% +1,340%, and +1,708%.Imagine how much you could profit with a steady stream of real-time picks from all our services that cover a number of strategies to suit a variety of investing and trading styles.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Itron, Inc. (ITRI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Itron und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Itron
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Itron
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Itron Inc.
Analysen zu Itron Inc.
Datum | Rating | Analyst | |
---|---|---|---|
28.02.2019 | Itron Buy | Needham & Company, LLC | |
27.02.2018 | Itron Buy | Canaccord Adams | |
26.07.2017 | Itron Neutral | Robert W. Baird & Co. Incorporated | |
01.03.2017 | Itron Buy | Needham & Company, LLC | |
14.11.2016 | Itron Buy | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
26.07.2017 | Itron Neutral | Robert W. Baird & Co. Incorporated | |
07.10.2015 | Itron Hold | Gabelli & Co | |
11.09.2015 | Itron Perform | Oppenheimer & Co. Inc. | |
05.05.2015 | Itron Market Perform | Northland Capital | |
12.02.2015 | Itron Market Perform | Northland Capital |
Datum | Rating | Analyst | |
---|---|---|---|
15.10.2012 | Itron sell | Stifel, Nicolaus & Co., Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Itron Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen